PBX1 and leukemia: Wnt/β-catenin pathway dysregulation has been reported in different B-ALL subtypes, such as TFC3/PBX1 B-ALL, where Wnt16b is aberrantly activated by the expression of the E2A-Pbx1 fusion protein to induce leukemia [126,127].